Dr. Martin Murphy
Chief Executive Officer
Board of Director
CEGX
India
Biography
Dr. Martin Murphy is the Chief Executive Officer of Syncona Partners LLP. Previously, he was a Partner at MVM Life Science Partners LLP, a leading venture capital company focused on life science and healthcare investments with $500m under management. During his time at MVM, Martin was a member of the Management and Investment Committees and led MVM’s European operations. He was involved in a number of investments including PregLem SA (sold to Gedeon Richter), Momenta Pharmaceuticals, Inc, (NASDAQ: MNTA), Healthcare Brands International (sold to Meda AB) and Heptares Therapeutics Ltd. Before MVM, Martin had roles with 3i Group plc and McKinsey & Company. Martin has a PhD in Biochemistry from Cambridge University.
Research Interest
Pharmaceutical science, Biochemistry
